The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Structures of the PKA RIα Holoenzyme with the FLHCC Driver J-PKAcα or Wild-Type PKAcα
Published version of a preprint
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The inherent flexibility of the J-domain enables the kinase to form hetero-tetrameric holoenzymes with RIα subunits, although with two alternative conformations14.”
From Defective internal allosteric network imparts dysfunctional ATP/substrate-binding cooperativity in oncogenic chimera of protein kinase A (2021) · cites this paper as [14]
In the citing paper
“Moreover, PKA-CDNAJB1 retains the ability to form stable holoenzymes with all regulatory (R) subunit isoforms, although with non-canonical arrangements, and more importantly, responds to cAMP activation13,14.”
From Defective internal allosteric network imparts dysfunctional ATP/substrate-binding cooperativity in oncogenic chimera of protein kinase A (2021) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tomasini, M. D., Wang, Y., Karamafrooz, A., Li, G., Beuming, T., Gao, J., Taylor, S. S., Veglia, G., & Simon, S. M. (2018) · Scientific Reports · doi:10.1038/s41598-017-18956-w · Cited by 30
Self-citation
Research works printed but not linked: 57
- Adams, 2010, PHENIX: a comprehensive Python-based system for macromolecular structure solution, Acta Crystallogr. Sect. D Biol. Crystallogr., 66, 213, 10.1107/S0907444909052925 · DOI · Paper page
- Amieux, 2002, The essential role of RI alpha in the maintenance of regulated PKA activity, Ann. N. Y. Acad. Sci., 968, 75, 10.1111/j.1749-6632.2002.tb04328.x · DOI · Paper page
- Amieux, 1997, Compensatory regulation of RIα protein levels in protein kinase A mutant mice, J. Biol. Chem., 272, 3993, 10.1074/jbc.272.7.3993 · DOI · Paper page
- Badireddy, 2011, Cyclic AMP analog blocks kinase activation by stabilizing inactive conformation: conformational selection highlights a new concept in allosteric inhibitor design, Mol. Cell. Proteomics, 10, 10.1074/mcp.M110.004390 · DOI
- Barros, 2017, Electrostatic interactions as mediators in the allosteric activation of protein kinase A RIα, Biochemistry, 56, 1536, 10.1021/acs.biochem.6b01152 · DOI
- Boettcher, 2011, Realizing the allosteric potential of the tetrameric protein kinase A RIα holoenzyme, Structure, 19, 265, 10.1016/j.str.2010.12.005 · DOI
- Bowers, K.J., Chow, D.E., Xu, H., Dror, R.O., Eastwood, M.P., Gregersen, B.A., Klepeis, J.L., Kolossvary, I., Moraes, M.A., Sacerdoti, F.D., et al. (2006). Scalable algorithms for molecular dynamics simulations on commodity clusters. In ACM/IEEE SC 2006 Conference (SC’06), (IEEE), pp. 43. · DOI · Paper page
- Brown, 2009, Novel isoform-specific interfaces revealed by PKA RIIβ holoenzyme structures, J. Mol. Biol., 393, 1070, 10.1016/j.jmb.2009.09.014 · DOI
- Bruystens, 2014, PKA RIα homodimer structure reveals an intermolecular interface with implications for cooperative cAMP binding and Carney complex disease, Structure, 22, 59, 10.1016/j.str.2013.10.012 · DOI · Paper page
- Cheng, 2009, Sensing domain dynamics in protein kinase A-Iα complexes by solution X-ray scattering, J. Biol. Chem., 284, 35916, 10.1074/jbc.M109.059493 · DOI
- Cheung, 2015, Structural insights into mis-regulation of protein kinase A in human tumors, Proc. Natl. Acad. Sci. U S A, 112, 1374, 10.1073/pnas.1424206112 · DOI · Paper page
- Cook, 1982, Adenosine cyclic 3’,5’-monophosphate dependent protein kinase: kinetic mechanism for the bovine skeletal muscle catalytic subunit, Biochemistry, 21, 5794, 10.1021/bi00266a011 · DOI · Paper page
- Craig, 1980, Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features, Cancer, 46, 372, 10.1002/1097-0142(19800715)46:2<372::AID-CNCR2820460227>3.0.CO;2-S · doi:10.1002/1097-0142(19800715)46:2<372::aid-cncr2820460227>3.0.co;2-s
- Darcy, 2015, The genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients, Oncotarget, 6, 755, 10.18632/oncotarget.2712 · DOI · Paper page
- Eggert, 2013, Epidemiology of fibrolamellar hepatocellular carcinoma in the USA, 2000–10, Gut, 62, 1667, 10.1136/gutjnl-2013-305164 · doi:10.1136/gutjnl-2013-305164
- El-Serag, 2004, Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study, Hepatology, 39, 798, 10.1002/hep.20096 · DOI
- Emsley, 2004, Coot: model-building tools for molecular graphics, Acta Crystallogr. Sect. D Biol. Crystallogr., 60, 2126, 10.1107/S0907444904019158 · DOI · Paper page
- Engelholm, 2017, CRISPR/Cas9 engineering of adult mouse liver demonstrates that the Dnajb1-Prkaca gene fusion is sufficient to induce tumors resembling fibrolamellar hepatocellular carcinoma, Gastroenterology, 153, 1662, 10.1053/j.gastro.2017.09.008 · DOI
- Graham, 2017, Fibrolamellar carcinoma in the Carney complex: PRKAR1A loss instead of the classic DNAJB1-PRKACA fusion, Hepatology, 68, 1441, 10.1002/hep.29719 · DOI · Paper page
- Greene, 2008, In vitro functional studies of naturally occurring pathogenic PRKAR1A mutations that are not subject to nonsense mRNA decay, Hum. Mutat., 29, 633, 10.1002/humu.20688 · DOI
- Harder, 2016, OPLS3: a force field providing broad coverage of drug-like small molecules and proteins, J. Chem. Theory Comput., 12, 281, 10.1021/acs.jctc.5b00864 · DOI · Paper page
- Hirakis, 2017, Molecular simulations reveal an unresolved conformation of the type IA protein kinase a regulatory subunit and suggest its role in the cAMP regulatory mechanism, Biochemistry, 56, 3885, 10.1021/acs.biochem.7b00461 · DOI
- Honeyman, 2014, Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma, Science, 343, 1010, 10.1126/science.1249484 · DOI · Paper page
- Ilouz, 2012, Localization and quaternary structure of the PKA RIβ holoenzyme, Proc. Natl. Acad. Sci. U S A, 109, 12443, 10.1073/pnas.1209538109 · DOI
- Kakar, 2005, Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis, Mod. Pathol., 18, 1417, 10.1038/modpathol.3800449 · doi:10.1038/modpathol.3800449
- Kastenhuber, 2017, DNAJB1-PRKACA fusion kinase interacts with β-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma, Proc. Natl. Acad. Sci. U S A, 114, 13076, 10.1073/pnas.1716483114 · DOI · Paper page
- Katzenstein, 2003, Fibrolamellar hepatocellular carcinoma in children and adolescents, Cancer, 97, 2006, 10.1002/cncr.11292 · DOI
- Kim, 2007, PKA-I holoenzyme structure reveals a mechanism for cAMP-dependent activation, Cell, 130, 1032, 10.1016/j.cell.2007.07.018 · DOI · Paper page
- Lalazar, 2018, Fibrolamellar carcinoma: recent advances and unresolved questions on the molecular mechanisms, Semin. Liver Dis., 38, 51, 10.1055/s-0037-1621710 · DOI · Paper page
- Li, 2000, Consequences of cAMP and catalytic-subunit binding on the flexibility of the A-kinase regulatory subunit, Biochemistry, 39, 15626, 10.1021/bi002196l · DOI
- Lim, 2014, Advances in fibrolamellar hepatocellular carcinoma: a review, Eur. J. Pediatr. Surg., 24, 461, 10.1055/s-0034-1396420 · doi:10.1055/s-0034-1396420
- Linglart, 2012, PRKAR1A and PDE4D mutations cause acrodysostosis but two distinct syndromes with or without GPCR-signaling hormone resistance, J. Clin. Endocrinol. Metab., 97, E2328, 10.1210/jc.2012-2326 · DOI
- Martyna, 1992, Nosé-Hoover chains: the canonical ensemble via continuous dynamics, J. Chem. Phys., 97, 2635, 10.1063/1.463940 · DOI · Paper page
- Mavros, 2012, A systematic review: treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma, J. Am. Coll. Surg., 215, 820, 10.1016/j.jamcollsurg.2012.08.001 · DOI
- McCoy, 2007, Phaser crystallographic software, J. Appl. Crystallogr., 40, 658, 10.1107/S0021889807021206 · DOI · Paper page
- Murshudov, 2011, REFMAC5 for the refinement of macromolecular crystal structures, Acta Crystallogr. D Biol. Crystallogr., 67, 355, 10.1107/S0907444911001314 · DOI · Paper page
- Oikawa, 2015, Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells, Nat. Commun., 6, 8070, 10.1038/ncomms9070 · DOI
- Otwinowski, 1997, [20] Processing of X-ray diffraction data collected in oscillation mode, Methods Enzymol., 276, 307, 10.1016/S0076-6879(97)76066-X · DOI · Paper page
- Park, 2012, Novel mutation in PRKAR1A in Carney complex, Korean J. Pathol., 46, 595, 10.4132/KoreanJPathol.2012.46.6.595 · DOI
- Riggle, 2016, Enhanced cAMP-stimulated protein kinase A activity in human fibrolamellar hepatocellular carcinoma, Pediatr. Res., 80, 110, 10.1038/pr.2016.36 · DOI · Paper page
- Riggle, 2016, Fibrolamellar hepatocellular carcinoma: mechanistic distinction from adult hepatocellular carcinoma, Pediatr. Blood Cancer, 63, 1163, 10.1002/pbc.25970 · DOI · Paper page
- Simon, 2015, Transcriptomic characterization of fibrolamellar hepatocellular carcinoma, Proc. Natl. Acad. Sci. U S A, 112, E5916, 10.1073/pnas.1424894112 · DOI · Paper page
- Søberg, 2017, Evolution of the cAMP-dependent protein kinase (PKA) catalytic subunit isoforms, PLoS One, 12, e0181091, 10.1371/journal.pone.0181091 · DOI
- Svergun, 1992, Determination of the regnlarization parameter in indirect-transform methods using perceptual criteria, J. Appl. Crystallogr., 25, 495, 10.1107/S0021889892001663 · DOI · Paper page
- Svergun, 1995, CRYSOL – a program to evaluate X-ray solution scattering of biological macromolecules from atomic coordinates, J. Appl. Crystallogr., 28, 768, 10.1107/S0021889895007047 · DOI · Paper page
- Taylor, 2012, Assembly of allosteric macromolecular switches: lessons from PKA, Nat. Rev. Mol. Cell Biol., 13, 646, 10.1038/nrm3432 · DOI · Paper page
- Terracciano, 2004, Fibrolamellar hepatocellular carcinoma occurring 5 years after hepatocellular adenoma in a 14-year-old girl: a case report with comparative genomic hybridization analysis, Arch. Pathol. Lab. Med., 128, 222, 10.5858/2004-128-222-FHCOYA · doi:10.5858/2004-128-222-fhcoya
- Torbenson, 2012, Fibrolamellar carcinoma: 2012 update, Scientifica (Cairo), 2012, 743790
- Tuckerman, 2006, A Liouville-operator derived measure-preserving integrator for molecular dynamics simulations in the isothermal-isobaric ensemble, J. Phys. A Math. Gen., 39, 5629, 10.1088/0305-4470/39/19/S18 · DOI · Paper page
- Veugelers, 2004, Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice, Proc. Natl. Acad. Sci. U S A, 101, 14222, 10.1073/pnas.0405535101 · DOI
- Weeda, 2013, Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma – results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience, Eur. J. Cancer, 49, 2698, 10.1016/j.ejca.2013.04.012 · DOI
- Wu, 2004, Crystal structures of RIα subunit of cyclic adenosine 5′-monophosphate (cAMP)-dependent protein kinase complexed with (R p)-adenosine 3′,5′-cyclic monophosphothioate and (S p)-adenosine 3′,5′-cyclic monophosphothioate, the phosphothioate analogues of cAMP, Biochemistry, 43, 6620, 10.1021/bi0302503 · DOI
- Wu, 2004, RIalpha subunit of PKA: a cAMP-free structure reveals a hydrophobic capping mechanism for docking cAMP into site B, Structure, 12, 1057, 10.1016/j.str.2004.03.022 · DOI
- Wu, 2007, PKA type IIalpha holoenzyme reveals a combinatorial strategy for isoform diversity, Science, 318, 274, 10.1126/science.1146447 · DOI · Paper page
- Zhang, 2012, Structure and allostery of the PKA RII tetrameric holoenzyme, Science, 335, 712, 10.1126/science.1213979 · DOI · Paper page
- Zhang, 2015, An isoform-specific myristylation switch targets type II PKA holoenzymes to membranes, Structure, 23, 1563, 10.1016/j.str.2015.07.007 · DOI · Paper page
- Zheng, 1993, 2.2 A refined crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MnATP and a peptide inhibitor, Acta Crystallogr. D Biol. Crystallogr., 49, 362, 10.1107/S0907444993000423 · DOI · Paper page
Cited by
Olivieri, C., Walker, C., Karamafrooz, A., Wang, Y., Manu, V. S., Porcelli, F., Blumenthal, D. K., Thomas, D. D., Bernlohr, D. A., Simon, S. M., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01819-6 · Cited by 27
Self-citation
Metadata
- Authors
- Cao, B., Lu, T.-W., Martinez Fiesco, J. A., Tomasini, M., Fan, L., Simon, S. M., Taylor, S. S., & Zhang, P.
- Venue
- Structure
- Publisher
- Elsevier BV
- Published
- 2019-05
- Volume
- 27
- Issue
- 5
- Pages
- 816-828.e4
- ISSN
- 0969-2126
- Cited by
- 33
- References
- 1
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 372 d)
- Funders
- FNLCR
- NIH (GM34921, 5R56CA207929)
- Department of Defense (CA160446)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Structures of the PKA RIα Holoenzyme with the FLHCC Driver J-PKAcα or Wild-Type PKAcα. https://app.cochat.ai/papers/10.1016/j.str.2019.03.001
- The paper
- Cao, B., Lu, T.-W., Martinez Fiesco, J. A., Tomasini, M., Fan, L., Simon, S. M., Taylor, S. S., & Zhang, P. (2019). Structures of the PKA RIα Holoenzyme with the FLHCC Driver J-PKAcα or Wild-Type PKAcα. Structure. https://doi.org/10.1016/j.str.2019.03.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.